Copyright Reports & Markets. All rights reserved.

Global Hemophilia A Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Hemophilia A Drug Market Overview

      • 1.1 Product Overview and Scope of Hemophilia A Drug
      • 1.2 Hemophilia A Drug Segment by Type
        • 1.2.1 Global Hemophilia A Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ATXF-8117
        • 1.2.3 BAY-1093884
        • 1.2.4 BIVV-001
        • 1.2.5 BS-027125
        • 1.2.6 Concizumab
        • 1.2.7 CSL-689
        • 1.2.8 Others
      • 1.3 Hemophilia A Drug Segment by Application
        • 1.3.1 Hemophilia A Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 ASCs
      • 1.3 Global Hemophilia A Drug Market by Region
        • 1.3.1 Global Hemophilia A Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Hemophilia A Drug Market Size
        • 1.4.1 Global Hemophilia A Drug Revenue (2014-2025)
        • 1.4.2 Global Hemophilia A Drug Production (2014-2025)

      2 Global Hemophilia A Drug Market Competition by Manufacturers

      • 2.1 Global Hemophilia A Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hemophilia A Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hemophilia A Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hemophilia A Drug Production Sites, Area Served, Product Types
      • 2.5 Hemophilia A Drug Market Competitive Situation and Trends
        • 2.5.1 Hemophilia A Drug Market Concentration Rate
        • 2.5.2 Hemophilia A Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hemophilia A Drug Production Market Share by Regions

      • 3.1 Global Hemophilia A Drug Production Market Share by Regions
      • 3.2 Global Hemophilia A Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hemophilia A Drug Production
        • 3.4.1 North America Hemophilia A Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hemophilia A Drug Production
        • 3.5.1 Europe Hemophilia A Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hemophilia A Drug Production (2014-2019)
        • 3.6.1 China Hemophilia A Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hemophilia A Drug Production (2014-2019)
        • 3.7.1 Japan Hemophilia A Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hemophilia A Drug Consumption by Regions

      • 4.1 Global Hemophilia A Drug Consumption by Regions
      • 4.2 North America Hemophilia A Drug Consumption (2014-2019)
      • 4.3 Europe Hemophilia A Drug Consumption (2014-2019)
      • 4.4 China Hemophilia A Drug Consumption (2014-2019)
      • 4.5 Japan Hemophilia A Drug Consumption (2014-2019)

      5 Global Hemophilia A Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Hemophilia A Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Hemophilia A Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hemophilia A Drug Price by Type (2014-2019)
      • 5.4 Global Hemophilia A Drug Production Growth by Type (2014-2019)

      6 Global Hemophilia A Drug Market Analysis by Applications

      • 6.1 Global Hemophilia A Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hemophilia A Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hemophilia A Drug Business

      • 7.1 Bayer AG
        • 7.1.1 Bayer AG Hemophilia A Drug Production Sites and Area Served
        • 7.1.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.1.3 Bayer AG Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 BioMarin Pharmaceutical Inc
        • 7.2.1 BioMarin Pharmaceutical Inc Hemophilia A Drug Production Sites and Area Served
        • 7.2.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bioverativ Inc
        • 7.3.1 Bioverativ Inc Hemophilia A Drug Production Sites and Area Served
        • 7.3.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.3.3 Bioverativ Inc Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Catalyst Biosciences Inc
        • 7.4.1 Catalyst Biosciences Inc Hemophilia A Drug Production Sites and Area Served
        • 7.4.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.4.3 Catalyst Biosciences Inc Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Chugai Pharmaceutical Co Ltd
        • 7.5.1 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Sites and Area Served
        • 7.5.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 CSL Ltd
        • 7.6.1 CSL Ltd Hemophilia A Drug Production Sites and Area Served
        • 7.6.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.6.3 CSL Ltd Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 DBV Technologies SA
        • 7.7.1 DBV Technologies SA Hemophilia A Drug Production Sites and Area Served
        • 7.7.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.7.3 DBV Technologies SA Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Dimension Therapeutics Inc
        • 7.8.1 Dimension Therapeutics Inc Hemophilia A Drug Production Sites and Area Served
        • 7.8.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.8.3 Dimension Therapeutics Inc Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 EpiVax Inc
        • 7.9.1 EpiVax Inc Hemophilia A Drug Production Sites and Area Served
        • 7.9.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.9.3 EpiVax Inc Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Expression Therapeutics LLC
        • 7.10.1 Expression Therapeutics LLC Hemophilia A Drug Production Sites and Area Served
        • 7.10.2 Hemophilia A Drug Product Introduction, Application and Specification
        • 7.10.3 Expression Therapeutics LLC Hemophilia A Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Green Cross Corp
      • 7.12 Idogen AB
      • 7.13 Immusoft Corp
      • 7.14 LFB SA
      • 7.15 mAbxience SA

      8 Hemophilia A Drug Manufacturing Cost Analysis

      • 8.1 Hemophilia A Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hemophilia A Drug
      • 8.4 Hemophilia A Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hemophilia A Drug Distributors List
      • 9.3 Hemophilia A Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hemophilia A Drug Market Forecast

      • 11.1 Global Hemophilia A Drug Production, Revenue Forecast
        • 11.1.1 Global Hemophilia A Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hemophilia A Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Hemophilia A Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hemophilia A Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hemophilia A Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hemophilia A Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hemophilia A Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hemophilia A Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hemophilia A Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hemophilia A Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Hemophilia A Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hemophilia A Drug Consumption Forecast (2019-2025)
      • 11.4 Global Hemophilia A Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hemophilia A Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Hemophilia A Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Hemophilia A Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemophilia A Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Bayer AG
        BioMarin Pharmaceutical Inc
        Bioverativ Inc
        Catalyst Biosciences Inc
        Chugai Pharmaceutical Co Ltd
        CSL Ltd
        DBV Technologies SA
        Dimension Therapeutics Inc
        EpiVax Inc
        Expression Therapeutics LLC
        Green Cross Corp
        Idogen AB
        Immusoft Corp
        LFB SA
        mAbxience SA

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ATXF-8117
        BAY-1093884
        BIVV-001
        BS-027125
        Concizumab
        CSL-689
        Others

        Segment by Application
        Clinic
        Hospital
        ASCs

        Buy now